XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Concentration Risk [Line Items]      
Rebate receivable $ 31,700   $ 35,200
Investments in equity-method investees 18,200   $ 17,000
Proportionate share of earnings in equity-method investees $ 1,205 $ 562  
Capital distribution received from investment   $ 500  
Revenue from Contract with Customer Benchmark | Company's Largest Payer      
Concentration Risk [Line Items]      
Concentration risk 16.00% 13.00%  
Contract term 2 years    
Revenue from Contract with Customer Benchmark | Governmental Programs      
Concentration Risk [Line Items]      
Concentration risk 18.00% 12.00%  
Accounts Receivable | Governmental Programs      
Concentration Risk [Line Items]      
Concentration risk 13.00%   15.00%
Cost of Goods and Service, Product and Service Benchmark | Medical Supply Vendors      
Concentration Risk [Line Items]      
Concentration risk 67.00% 70.00%